Go Pro
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel Free VKTX Stock Alerts

Viking Therapeutics (VKTX) Short Interest Ratio & Short Volume

Viking Therapeutics logo
$34.26 +0.96 (+2.88%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$34.23 -0.03 (-0.08%)
As of 08/7/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Viking Therapeutics Short Interest Overview

As of July 15, 2026, Viking Therapeutics (VKTX) had a short interest of 23.16 million shares sold short, representing 21.06% of the public float. This marks a -1.48% decrease in short interest since the prior report. The short interest ratio (days to cover) is 9.8, meaning it would take 9.8 days of the average trading volume of 1.97 million shares to cover all short positions.

Current Short Interest
23,160,859 shares
Previous Short Interest
23,507,768 shares
Change Vs. Previous Month
-1.48%
Dollar Volume Sold Short
$875.71 million
Short Interest Ratio
9.8 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
116,650,000 shares
Short Percent of Float
21.06%
Today's Trading Volume
1,398,050 shares
Average Trading Volume
1,969,008 shares
Today's Volume Vs. Average
71%
Short Selling Viking Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Viking Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

VKTX Short Interest Over Time

VKTX Days to Cover Over Time

VKTX Percentage of Float Shorted Over Time

Viking Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202623,160,859 shares $875.71 million -1.5%21.1%9.84 $37.81
6/30/202623,507,768 shares $917.04 million +0.8%21.4%6.65 $39.01
6/15/202623,318,798 shares $690.94 million +4.2%21.2%11.64 $29.63
5/29/202622,371,620 shares $732.45 million +0.4%20.3%11.69 $32.74
5/15/202622,278,429 shares $674.37 million -1.7%20.3%11.2 $30.27
4/30/202622,652,414 shares $706.30 million -2.0%20.6%8.92 $31.18
4/15/202623,110,005 shares $819.25 million -3.7%21.0%11.05 $35.45
3/31/202624,006,215 shares $781.16 million -1.2%21.8%9.82 $32.54
3/13/202624,296,409 shares $865.68 million -0.1%21.9%9.88 $35.63
2/27/202624,324,779 shares $823.15 million -7.0%22.0%10.84 $33.84
2/13/202626,159,249 shares $758.62 million +0.4%23.8%6.93 $29.00
1/30/202626,061,262 shares $756.82 million +3.7%24.0%9.88 $29.04
1/15/202625,128,113 shares $801.08 million +3.2%23.2%5.97 $31.88
12/31/202524,344,265 shares $856.43 million +1.3%22.5%11.72 $35.18
12/15/202524,029,319 shares $868.66 million +4.5%22.2%8.78 $36.15
11/28/202522,990,072 shares $845.57 million -7.2%21.2%7.77 $36.78
11/14/202524,785,654 shares $969.37 million +2.5%22.9%5.4 $39.11
10/31/202524,173,606 shares $920.53 million -5.0%22.3%5.41 $38.08
10/15/202525,450,000 shares $893.80 million -7.6%23.5%4 $35.12
9/30/202527,540,000 shares $723.75 million +2.0%N/A4.4 $26.28
9/15/202527,010,000 shares $650.40 million +1.2%N/A4.4 $24.08
8/31/202526,680,000 shares $721.69 million -3.0%24.7%4.5 $27.05
8/15/202527,510,000 shares $1.10 billion -4.2%N/A5 $40.03
7/31/202528,700,000 shares $934.76 million +0.4%26.6%7.8 $32.57
7/15/202528,600,000 shares $878.02 million +88,996.6%N/A7.8 $30.70
6/30/202532,100 shares $850.65 thousand -99.9%0.0%0.2 $26.50
6/15/202528,470,000 shares $742.50 million +6.6%26.4%7.5 $26.08
5/31/202526,710,000 shares $720.64 million +4.6%25.2%6.9 $26.98
5/15/202525,540,000 shares $699.80 million -3.8%24.0%6.2 $27.40
4/30/202526,540,000 shares $766.21 million +4.2%N/A5.7 $28.87
4/15/202525,460,000 shares $588.38 million -0.6%24.0%5.6 $23.11
3/31/202525,620,000 shares $618.72 million +5.8%24.1%5.6 $24.15
3/15/202524,210,000 shares $747.85 million +1.3%22.8%5.4 $30.89
2/28/202523,910,000 shares $690.28 million -4.8%22.5%5.6 $28.87
2/15/202525,110,000 shares $765.35 million +4.9%23.6%6.1 $30.48
1/31/202523,930,000 shares $783.71 million +18.5%N/A5.9 $32.75
1/15/202520,200,000 shares $704.17 million +3.8%N/A4.3 $34.86
12/31/202419,470,000 shares $783.47 million +6.4%N/A4.5 $40.24
12/15/202418,300,000 shares $860.65 million +1.3%N/A4.3 $47.03
11/30/202418,070,000 shares $956.63 million +6.4%N/A4.3 $52.94
Socialists Just Took Over America’s Biggest City. This 41-Year Wall Street Veteran Says They’re About to Get Blindsided. (Ad)

A 41-year Wall Street veteran who recommended Apple at $1, NVIDIA at $1.10, and Amazon at $1.77 says America's affordability crisis could be nearing its end. He points to an emerging economic trend he believes could trigger the biggest price collapse in the U.S. since the late 1800s, reshaping the debate over socialism's rise.tc pixel

Watch his free presentation on the coming price shift now
11/15/202416,990,000 shares $842.36 million +27.9%N/A4.1 $49.58
10/31/202413,280,000 shares $963.33 million -7.7%N/A3.4 $72.54
10/15/202414,390,000 shares $940.82 million -0.6%N/A4 $65.38
9/30/202414,480,000 shares $916.73 million -9.0%N/A4.1 $63.31
9/15/202415,910,000 shares $1.06 billion -7.2%N/A4.1 $66.73
8/31/202417,140,000 shares $1.10 billion -3.2%N/A4.5 $64.12
8/15/202417,700,000 shares $1.01 billion +5.0%N/A4.6 $57.00
7/31/202416,860,000 shares $961.02 million +11.7%N/A4.3 $57.00
7/15/202415,100,000 shares $896.64 million -10.3%N/A4.4 $59.38
6/30/202416,830,000 shares $892.16 million +32.8%N/A5 $53.01
6/15/202412,670,000 shares $659.09 million +2.9%N/A3.6 $52.02
5/31/202412,310,000 shares $766.42 million +1.2%N/A3.2 $62.26
5/15/202412,170,000 shares $949.38 million +0.5%N/A2 $78.01
4/30/202412,110,000 shares $963.71 million +8.6%N/A1.9 $79.58
4/15/202411,150,000 shares $746.49 million +17.1%N/A1.8 $66.95
3/31/20249,520,000 shares $780.64 million -14.5%N/A1.5 $82.00
3/15/202411,140,000 shares $696.92 million -9.3%N/A1.8 $62.56
2/29/202412,280,000 shares $946.17 million +2.2%N/A2.2 $77.05
2/15/202412,020,000 shares $382.84 million -7.0%N/A3 $31.85
1/31/202412,920,000 shares $311.89 million -5.8%N/A4.6 $24.14
1/15/202413,710,000 shares $293.94 million +1.9%N/A5.3 $21.44
12/31/202313,460,000 shares $250.49 million -7.8%N/A5.3 $18.61
12/15/202314,600,000 shares $275.94 million -5.3%N/A5.9 $18.90
11/30/202315,420,000 shares $188.43 million -9.1%N/A6.4 $12.22
11/15/202316,970,000 shares $187.18 million +3.4%N/A8.5 $11.03
10/31/202316,420,000 shares $161.08 million +11.0%N/A8.6 $9.81
10/15/202314,800,000 shares $162.06 million +6.6%N/A7.7 $10.95
9/30/202313,890,000 shares $153.76 million +1.8%N/A7.8 $11.07
9/15/202313,640,000 shares $201.46 million +5.7%N/A6.6 $14.77
8/31/202312,910,000 shares $178.29 million -5.0%N/A5.6 $13.81
8/15/202313,590,000 shares $201.27 million +14.8%N/A5.5 $14.81
7/31/202311,840,000 shares $171.68 million -2.7%N/A4.2 $14.50
7/15/202312,170,000 shares $189.61 million +0.7%N/A4 $15.58
6/30/202312,090,000 shares $195.98 million +9.2%N/A3.6 $16.21
6/15/202311,070,000 shares $248.63 million -6.9%N/A2.2 $22.46
5/31/202311,890,000 shares $261.10 million -1.2%N/A2.5 $21.96
5/15/202312,030,000 shares $264.54 million +3.8%N/A2.5 $21.99
4/30/202311,590,000 shares $246.98 million +1.3%N/A2.6 $21.31
4/15/202311,440,000 shares $214.50 million +1.6%N/A2.7 $18.75
3/31/202311,260,000 shares $187.48 million +112.1%N/A2.9 $16.65
3/15/20235,310,000 shares $56.71 million +9.5%7.8%1.8 $10.68
2/28/20234,850,000 shares $53.40 million +4.1%7.1%1.3 $11.01
2/15/20234,660,000 shares $51.91 million +17.7%6.9%1.3 $11.14
1/31/20233,960,000 shares $34.69 million -33.2%5.9%1.1 $8.76
1/15/20235,930,000 shares $53.07 million +4.2%8.9%1.7 $8.95
12/30/20225,690,000 shares $53.49 million +201.1%8.4%1.7 $9.40
12/15/20221,890,000 shares $7.28 million +6.8%2.8%0.6 $3.85
11/30/20221,770,000 shares $7.17 million -1.7%2.6%2.3 $4.05
11/15/20221,800,000 shares $8.05 million -5.3%2.7%2.4 $4.47
10/31/20221,900,000 shares $7.79 million +6.2%2.8%2.9 $4.10
SpaceX pays a 10X launch penalty (Ad)

SpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One under $5 company's High Altitude Head Start technology could bring that down to $20,000 per launch, or $2 million across 100 missions - a 10X cost advantage. It is already flying with paying customers, but shares may not stay this cheap once Wall Street notices.tc pixel

Click here to reveal the ticker before Wall Street catches on
10/15/20221,790,000 shares $5.85 million -4.8%2.7%2.6 $3.27
9/30/20221,880,000 shares $5.11 million -2.6%2.8%3 $2.72
9/15/20221,930,000 shares $6.41 million -4.5%2.8%2.2 $3.32
8/31/20222,020,000 shares $6.42 million -3.4%3.0%2.1 $3.18
8/15/20222,090,000 shares $8.13 million -3.7%3.1%1.9 $3.89
7/31/20222,170,000 shares $0.00 -11.4%3.2%1.9 $0.00
7/15/20222,450,000 shares $9.07 million -9.6%3.6%2.2 $3.70
6/30/20222,710,000 shares $7.83 million -41.1%3.9%2.4 $2.89
6/15/20224,600,000 shares $9.98 million -1.9%6.7%4.4 $2.17
5/31/20224,690,000 shares $10.41 million +4.5%6.8%4.9 $2.22
5/15/20224,490,000 shares $10.46 million +16.3%6.5%4.8 $2.33
4/30/20223,860,000 shares $9.19 million +4.3%5.6%3.9 $2.38
4/15/20223,700,000 shares $10.21 million +3.9%5.4%3.4 $2.76
3/31/20223,560,000 shares $10.68 million -20.2%5.1%3.2 $3.00
3/15/20224,460,000 shares $13.51 million +2.5%6.4%3.9 $3.03
2/28/20224,350,000 shares $14.57 million +4.8%6.2%4.1 $3.35
2/15/20224,150,000 shares $15.69 million -4.2%5.9%3.8 $3.78
1/31/20224,330,000 shares $16.06 million +19.0%6.2%4.5 $3.71
1/15/20223,640,000 shares $15.43 million -0.6%5.2%4 $4.24
12/31/20213,660,000 shares $16.84 million -12.0%5.3%5.1 $4.60
12/15/20214,160,000 shares $20.09 million -15.8%5.9%6.1 $4.83
11/30/20214,940,000 shares $26.23 million +3.4%7.0%8 $5.31
11/15/20214,780,000 shares $28.73 million -4.0%6.8%7.7 $6.01
10/29/20214,980,000 shares $28.98 million +4.8%7.1%8 $5.82
10/15/20214,750,000 shares $28.55 million -6.3%6.8%7.8 $6.01
9/30/20215,070,000 shares $31.84 million -13.5%7.2%8 $6.28
9/15/20215,860,000 shares $38.03 million -8.0%8.3%8.4 $6.49
8/31/20216,370,000 shares $42.11 million -13.7%9.1%7.9 $6.61
8/13/20217,380,000 shares $43.62 million -9.0%10.5%8.4 $5.91

VKTX Short Interest - Frequently Asked Questions

Short interest is the volume of Viking Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 23,160,859 shares of VKTX short. 21.06% of Viking Therapeutics' shares are currently sold short. Learn More on Viking Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VKTX shares currently have a short interest ratio of 9.8. Learn More on Viking Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 21.06% of Viking Therapeutics' floating shares are currently sold short.

Viking Therapeutics saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 23,160,859 shares, a drop of 1.5% from the previous total of 23,507,768 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

21.06% of Viking Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Viking Therapeutics: Madrigal Pharmaceuticals, Inc. (10.86%), Eli Lilly and Company (1.09%), Pfizer Inc. (2.89%), Elanco Animal Health Incorporated (7.25%), Arrowhead Pharmaceuticals, Inc. (7.10%), Axsome Therapeutics, Inc. (7.40%), Abivax SA Sponsored ADR (4.61%), Krystal Biotech, Inc. (13.65%), Summit Therapeutics PLC (29.15%), Cytokinetics, Incorporated (14.07%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling VKTX is an investing strategy that aims to generate trading profit from Viking Therapeutics as its price is falling. VKTX shares are trading up $0.96 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Viking Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VKTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VKTX, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like VKTX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:VKTX) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners
Trump is bulldozing nuclear's 50-year blockade
Four advanced test reactors just reached criticality, according to the Department of Energy, a milestone that ...
Monument Traders Alliance | Sponsoredtc pixel
What Elon told his top shareholders in Texas
Late last year, Elon Musk gathered top shareholders at Tesla's Texas Gigafactory to unveil a plan to double Am...
Banyan Hill Publishing | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
A valet parking cars made $37,212 in one weekend
Jack was parking cars for tips with no college degree. His first 18 months trading were rough—he was down mone...
Tim Sykes | Sponsoredtc pixel
A Secret Plan to End Trump in November?
A White House insider with close ties to the Trump family is speaking out about what he calls the biggest poli...
Paradigm Press | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
The world's #2 gold miner is running on fumes [it has to buy]
Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...
Golden Portfolio | Sponsoredtc pixel